Royalty Pharma plc (RPRX)
NASDAQ: RPRX · IEX Real-Time Price · USD
27.27
-0.61 (-2.19%)
At close: May 17, 2024, 4:00 PM
27.56
+0.29 (1.06%)
After-hours: May 17, 2024, 7:15 PM EDT
Royalty Pharma Revenue
Royalty Pharma had revenue of $2.24B in the twelve months ending March 31, 2024, down -5.11% year-over-year. Revenue in the quarter ending March 31, 2024 was $567.98M, a -16.96% decrease year-over-year. In the year 2023, Royalty Pharma had annual revenue of $2.35B with 5.24% growth.
Revenue (ttm)
$2.24B
Revenue Growth
-5.11%
P/S Ratio
5.50
Revenue / Employee
$25,152,371
Employees
89
Market Cap
12.31B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.35B | 117.34M | 5.24% |
Dec 31, 2022 | 2.24B | -52.25M | -2.28% |
Dec 31, 2021 | 2.29B | 167.11M | 7.87% |
Dec 31, 2020 | 2.12B | 308.10M | 16.98% |
Dec 31, 2019 | 1.81B | 19.36M | 1.08% |
Dec 31, 2018 | 1.79B | 196.96M | 12.33% |
Dec 31, 2017 | 1.60B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Fresenius Medical Care AG & Co. KGaA | 21.17B |
Tenet Healthcare | 20.91B |
DaVita | 12.34B |
Smith & Nephew | 5.55B |
Charles River Laboratories International | 4.11B |
Incyte | 3.77B |
United Therapeutics | 2.50B |
Medpace Holdings | 1.96B |
RPRX News
- 5 days ago - Royalty Pharma to Present at Upcoming Investor Conferences - GlobeNewsWire
- 9 days ago - Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab - GlobeNewsWire
- 16 days ago - Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma - Business Wire
- 4 weeks ago - Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024 - GlobeNewsWire
- 4 weeks ago - Royalty Pharma Declares Second Quarter 2024 Dividend - GlobeNewsWire
- 2 months ago - Royalty Pharma to Present at TD Cowen's 44th Annual Health Care Conference - GlobeNewsWire
- 3 months ago - Royalty Pharma Reports Q4 and Full Year 2023 Results - GlobeNewsWire
- 3 months ago - Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024 - GlobeNewsWire